Oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy

Jornal de Pediatria

Volumn 85, Issue 6, 2009, Pages 531-535

  Cagol, Ângela Rech ^a,b,c   De Castro Junior, Cláudio Galvão ^a,c   Martins, Maria Cristina ^c   Machado, Adão Leal ^a   Ribeiro, Renato Chagas ^c   Gregianin, Lauro J ^a,c   Brunetto, Algemir Lunardi ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Cancer; Neutropenia; Pediatrics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTINEOPLASTIC AGENT; CEFEPIME; CIPROFLOXACIN; PLACEBO;

ACUTE LEUKEMIA; ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BRAZIL; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; EWING SARCOMA; FEBRILE NEUTROPENIA; FEMALE; GONAD TUMOR; HEPATOBLASTOMA; HOSPITAL; HOSPITALIZATION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; ONCOLOGY; OSTEOSARCOMA; POPULATION; RANDOMIZED CONTROLLED TRIAL; RETINOBLASTOMA; RHABDOMYOSARCOMA; RISK; SOFT TISSUE SARCOMA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; NEOPLASMS; NEUTROPENIA;

EID: 75749124637     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1956     Document Type: Article

References (13)

1. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038-51.
2. Santolaya ME, Alvarez AM, Avilés EL, et al. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenic at low risk for invasive bacterial infection. J Clin Oncol. 2004; 22:3784-9.
3. Kern WV, Cometta A, de Bock R, et al. Oral versus intravenous empiric therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med. 1999; 341:312-8.
4. Freifeld A, Marchigiani D, Walsh T, et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med. 1999; 341:305-11.
5. Shah A, Lettieri J, Kaiser L, et al. Comparative pharmacokinetics and safety of ciprofloxacin 400mg i.v. thrice daily versus 750mg po twice daily. J Antimicrob Chemother. 1994; 33:795-801.
6. Klastersky J, Paesmans M, Georgala A, et al. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol. 2006; 24: 4129-34.
7. Paganini H, Gómez S, Ruvinsky S, et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease. Cancer. 2003; 97:1775-80.
8. Gupta A, Swaroop C, Agarwala S, Bakhshi S. Randomized controlled trial comparing efficacy of oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low risk febrile neutropenia. 2008 ASCO Annual Meeting. 2008; Abstract No 10020.
9. Petrilli AS, Dantas LS, Campos MC, et al. Oral Ciprofloxacin vs intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Ped Oncol. 2000; 34:87-91.
10. Wicki S, Keisker A, Aebi C, Leibundgut K, Hirt A, Ammann RA. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy? Pediatr Blood Cancer. 2008;51:778-783.
11. Secmeer G, Devrim I, Kara A, et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol. 2007; 29:107-11.
12. Mullen CA. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients. Ped Infect Dis J. 2003; 22:1138-42.
13. Castagnola E, Boni L, Giachino M, et al. A multicenter, randomized, double-blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J. 2003; 22:359-65.